Giulia Saponaro
About
Giulia Saponaro is a scholar working on Physiology, Organic Chemistry and Molecular Biology.
According to data from OpenAlex, Giulia Saponaro has authored 20 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Organic Chemistry and 10 papers in Molecular Biology. Recurrent topics in Giulia Saponaro's work include Adenosine and Purinergic Signaling (11 papers), Synthesis and Biological Evaluation (8 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Giulia Saponaro is often cited by papers focused on Adenosine and Purinergic Signaling (11 papers), Synthesis and Biological Evaluation (8 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Giulia Saponaro collaborates with scholars based in Italy, Palestinian Territory and Netherlands. Giulia Saponaro's co-authors include Delia Preti, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Pier Andrea Borea, Katia Varani, Stefania Baraldi, Romeo Romagnoli, Allan R. Moorman, Fabrizio Vincenzi and A Szállaśi and has published in prestigious journals such as Pain, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.
In The Last Decade
Giulia Saponaro
20 papers receiving 435 citations
Peers
Giulia Saponaro
Graham N. Maw United Kingdom
Grażyna Chłoń‐Rzepa Poland
Carl D. Davis United States
Agnieszka Jankowska Poland
David K. O’Dell United States
Jae Yang Kong South Korea
Samuele Maramai Italy
Hee Jeong Seo South Korea
Krzysztof Pociecha Poland
Jerome F. Daanen United States
Citations per year, relative to Giulia Saponaro Giulia Saponaro (= 1×)
peers
Graham N. Maw
Countries citing papers authored by Giulia Saponaro
Since
Specialization
Citations
This map shows the geographic impact of Giulia Saponaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Saponaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Saponaro more than expected).
Fields of papers citing papers by Giulia Saponaro
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Giulia Saponaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Saponaro. The network helps show where Giulia Saponaro may publish in the future.
Co-authorship network of co-authors of Giulia Saponaro
This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Saponaro. A scholar is included among the top collaborators of Giulia Saponaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Saponaro. Giulia Saponaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.. (2016). Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists. European Journal of Medicinal Chemistry. 113. 11–27.
2.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Emanuela Ruggiero, et al.. (2015). Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH). European Journal of Medicinal Chemistry. 97. 289–305.
3.
Baraldi, Pier Giovanni, Stefania Baraldi, Giulia Saponaro, et al.. (2015). One-Pot Reaction To Obtain N,N′-Disubstituted Guanidines of Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine Scaffold as Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 58(13). 5355–5360.
4.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Stefania Baraldi, et al.. (2015). Synthesis and Biological Evaluation of Pyrazolo[3,4-<i>b</i>]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors. Medicinal Chemistry. 11(4). 342–353.
5.
Preti, Delia, Giulia Saponaro, & A Szállaśi. (2015). Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists. Pharmaceutical Patent Analyst. 4(2). 75–94.
6.
Preti, Delia, Pier Giovanni Baraldi, Giulia Saponaro, et al.. (2015). Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5′-N-ethylcarboxamidoadenosines as Potent and Selective Agonists of the A2AAdenosine Receptor. Journal of Medicinal Chemistry. 58(7). 3253–3267.
7.
Romagnoli, Romeo, Pier Giovanni Baraldi, Adriaan P. IJzerman, et al.. (2014). Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1Adenosine Receptor Based on 2-Amino-3-(4′-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene. Journal of Medicinal Chemistry. 57(18). 7673–7686.
8.
Romagnoli, Romeo, Pier Giovanni Baraldi, María Dora Carriòn, et al.. (2013). Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A1 adenosine receptor. Bioorganic & Medicinal Chemistry. 22(1). 148–166.
9.
Vincenzi, Fabrizio, Martina Targa, Carmen Corciulo, et al.. (2013). Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. Pain. 154(6). 864–873.
10.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Giulia Saponaro, et al.. (2013). Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists. Journal of Medicinal Chemistry. 56(3). 1098–1112.
11.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Giulia Saponaro, et al.. (2013). Discovery of 7-Oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as Potent and Selective CB2Cannabinoid Receptor Inverse Agonists. Journal of Medicinal Chemistry. 56(11). 4482–4496.
12.
Baraldi, Pier Giovanni, Giulia Saponaro, Romeo Romagnoli, et al.. (2012). Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 55(11). 5380–5390.
13.
Baraldi, Pier Giovanni, Romeo Romagnoli, Giulia Saponaro, et al.. (2012). 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation. Bioorganic & Medicinal Chemistry. 20(5). 1690–1698.
14.
Baraldi, Pier Giovanni, Giulia Saponaro, Allan R. Moorman, et al.. (2012). 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists. Journal of Medicinal Chemistry. 55(14). 6608–6623.
15.
Baraldi, Pier Giovanni, Stefania Baraldi, Giulia Saponaro, et al.. (2011). Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2BAdenosine Receptor Antagonists. Journal of Medicinal Chemistry. 55(2). 797–811.
16.
Baraldi, Pier Giovanni, Delia Preti, Abdel Naser Zaid, et al.. (2011). New 2-Heterocyclyl-imidazo[2,1-i]purin-5-one Derivatives as Potent and Selective Human A3Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. 54(14). 5205–5220.
17.
Baraldi, Pier Giovanni, Giulia Saponaro, Mojgan Aghazadeh Tabrizi, et al.. (2011). Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 20(2). 1046–1059.
18.
Baraldi, Pier Giovanni, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.. (2008). Structure–activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A3 adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 16(24). 10281–10294.
19.
Tabrizi, Mojgan Aghazadeh, Pier Giovanni Baraldi, Delia Preti, et al.. (2007). 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry. 16(5). 2419–2430.
20.
Baraldi, Pier Giovanni, Delia Preti, Mojgan Aghazadeh Tabrizi, et al.. (2007). N6-[(Hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5′-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor. Bioorganic & Medicinal Chemistry. 15(7). 2514–2527.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Graham N. Maw Breakdown of academic impact, for papers by Grażyna Chłoń‐Rzepa Breakdown of academic impact, for papers by Carl D. Davis Breakdown of academic impact, for papers by Agnieszka Jankowska Breakdown of academic impact, for papers by David K. O’Dell Breakdown of academic impact, for papers by Jae Yang Kong Breakdown of academic impact, for papers by Samuele Maramai Breakdown of academic impact, for papers by Hee Jeong Seo Breakdown of academic impact, for papers by Krzysztof Pociecha Breakdown of academic impact, for papers by Jerome F. Daanen